about
Tumor treating fields: a novel treatment modality and its use in brain tumorsThe placebo effect: illness and interpersonal healing.Network analysis of the genomic basis of the placebo effect.Review of a study of duloxetine for painful chemotherapy-induced peripheral neuropathy.Placebo response in the prophylaxis of migraine: a meta-analysis.Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast CancerComplementary and alternative drug therapy versus science-oriented medicine.Research methodology: cancer cachexia syndrome.Treatment of unintentional weight loss in patients with cancer.A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancerThe development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice.Mistletoe treatment in cancer-related fatigue: a case report.Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical researchA meta-analysis of the relationship between response expectancies and cancer treatment-related side effects.Is Participation in Cancer Phase I Trials Really Therapeutic?Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression.Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
P2860
Q28073779-E008E139-617D-43FF-8F0D-EFD12677A17CQ33621740-7A45ACE1-F8D7-4D30-90E3-B87758139C0DQ33752381-836E32DC-2267-4ED8-9EF0-1A4B9854F132Q33886065-2C2E4927-BE46-49C4-87CF-CA2A99A879F2Q34621702-0E09ABDF-84CC-443D-A314-0DC197438E9FQ35770292-D4BA1E56-AF78-4001-B829-5C13EB09DE40Q35779270-64B8B50E-9059-4F91-81AE-EEFA1A0BED10Q35872798-A2CB62F0-1CDC-4C38-9AB3-AF92413A0BA0Q36278408-74194F26-0923-4596-B754-152A2BFA6EBBQ36334926-2BD40032-49A3-4DC2-A52F-E1FE395F3AFCQ36502310-67020A83-56CE-4807-B72C-43B9D1780978Q37126248-B501A619-3BFF-4426-82D8-485699075E9CQ37262806-E35382FF-0E81-48EA-8ABA-306A391766B2Q37439549-AA7097BF-30C5-4491-B910-E00DDB5D3CECQ37660474-B476BA38-8F2C-4ED3-9B65-741D4DC54319Q37756336-455BB1BA-0C7A-426A-9827-7A430ADF773FQ42509934-8CAAD064-E29E-4C4B-A0E1-AC78D132280BQ44867008-9658E93A-884B-4146-BA5E-0DC19455F015
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Placebo effects in oncology.
@ast
Placebo effects in oncology.
@en
type
label
Placebo effects in oncology.
@ast
Placebo effects in oncology.
@en
prefLabel
Placebo effects in oncology.
@ast
Placebo effects in oncology.
@en
P2860
P356
P1476
Placebo effects in oncology.
@en
P2093
Gisèle Chvetzoff
Ian F Tannock
P2860
P356
10.1093/JNCI/95.1.19
P407
P577
2003-01-01T00:00:00Z